![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
"Pay Attention!!" ADHD Through the Lifespan
This course reviews current scientific knowledge and clinical approaches to Attention-Deficit/Hyperactivity Disorder (ADHD) and examines its impact on development, functioning and health outcomes.
Anthony L. Rostain, M.D., M.A. is Professor of Psychiatry and Pediatrics at the Perelman School of Medicine of the University of Pennsylvania. He is Director of Education for the Department of Psychiatry where he is responsible for overseeing medical student education, residency, and fellowship training. He is triple boarded in pediatrics, adult psychiatry, and child and adolescent psychiatry. His primary clinical focus is "lifespan neurodevelopmental psychiatry," treating patients of all ages with Attention-Deficit/Hyperactivity Disorder, Autistic Spectrum Disorders (including Asperger Syndrome/High Functioning Autism), Tourette Syndrome, Learning Disabilities (Verbal and Nonverbal), and social communication disorders. ....
Dr. Rostain's research interests have focused on improving clinical outcomes for patients with ADHD and other neuropsychiatric disorders, and in creating effective service systems for high risk children, youth, and families. He completed a study of combined medication and cognitive-behavioral therapy (CBT) for adults with ADHD which served as the basis of a textbook on this topic. He is currently involved in studies of differential therapeutic efficacy of medication and CBT, of developmental processes in young adults with ADHD, and of predictors of treatment response for patients with co-morbid conditions such as anxiety and substance abuse.
Week 1: Basics
•Diagnostic Criteria
•Prevalence, Epidemiology
•Clinical Case Presentations - Children, adolescents, adults
Weeks 2-5: Biology
•Genetic Factors
•Prenatal and Perinatal Factors
•Neuroanatomy
•Neurochemistry
•Summary of Neurobiology of ADHD
Week 6: Psychology
•Intellectual Development
•Learning Disabilities, Speech and Language Disorders
•Emotional Self Control and Motivation
•Executive Functioning - Working Memory, Organization Planning
Week 7: Health & Long Term Outcomes
•Health Status/Sleep Problems
•Risk Taking Behaviors (Smoking, Sexuality, Substance Abuse)
•Accidents, Injuries, Driving Difficulties
•Long Term Outcomes of ADHD
Comorbid Conditions
•Externalizing Disorders (ODD, CD) and Substance Abuse
•Internalizing Disorders (i.e. Mood and Anxiety Disorders)
Week 8: Assessment
•Diagnostic Interviewing
•Behavior Rating Scales, School Performance Measures
Weeks 9-10: Medical Treatment
•Medications - Stimulants / Review of the Literature
•Medications - Stimulants / Mechanisms of Action
•Medications - Misuse and Abuse of Stimulants
•Medications - Atomoxetine / Alpha Agonists
Weeks 11-12: Treatment 2
•Behavior Management: Home and School
•Exercise, Nutrition, Sleep Hygiene
•Cognitive Behavioral Therapy
•Neurocognitive Training
This course reviews current scientific knowledge and clinical approaches to Attention-Deficit/Hyperactivity Disorder (ADHD) and examines its impact on development, functioning and health outcomes.
Anthony L. Rostain, M.D., M.A. is Professor of Psychiatry and Pediatrics at the Perelman School of Medicine of the University of Pennsylvania. He is Director of Education for the Department of Psychiatry where he is responsible for overseeing medical student education, residency, and fellowship training. He is triple boarded in pediatrics, adult psychiatry, and child and adolescent psychiatry. His primary clinical focus is "lifespan neurodevelopmental psychiatry," treating patients of all ages with Attention-Deficit/Hyperactivity Disorder, Autistic Spectrum Disorders (including Asperger Syndrome/High Functioning Autism), Tourette Syndrome, Learning Disabilities (Verbal and Nonverbal), and social communication disorders. ....
Dr. Rostain's research interests have focused on improving clinical outcomes for patients with ADHD and other neuropsychiatric disorders, and in creating effective service systems for high risk children, youth, and families. He completed a study of combined medication and cognitive-behavioral therapy (CBT) for adults with ADHD which served as the basis of a textbook on this topic. He is currently involved in studies of differential therapeutic efficacy of medication and CBT, of developmental processes in young adults with ADHD, and of predictors of treatment response for patients with co-morbid conditions such as anxiety and substance abuse.
Week 1: Basics
•Diagnostic Criteria
•Prevalence, Epidemiology
•Clinical Case Presentations - Children, adolescents, adults
Weeks 2-5: Biology
•Genetic Factors
•Prenatal and Perinatal Factors
•Neuroanatomy
•Neurochemistry
•Summary of Neurobiology of ADHD
Week 6: Psychology
•Intellectual Development
•Learning Disabilities, Speech and Language Disorders
•Emotional Self Control and Motivation
•Executive Functioning - Working Memory, Organization Planning
Week 7: Health & Long Term Outcomes
•Health Status/Sleep Problems
•Risk Taking Behaviors (Smoking, Sexuality, Substance Abuse)
•Accidents, Injuries, Driving Difficulties
•Long Term Outcomes of ADHD
Comorbid Conditions
•Externalizing Disorders (ODD, CD) and Substance Abuse
•Internalizing Disorders (i.e. Mood and Anxiety Disorders)
Week 8: Assessment
•Diagnostic Interviewing
•Behavior Rating Scales, School Performance Measures
Weeks 9-10: Medical Treatment
•Medications - Stimulants / Review of the Literature
•Medications - Stimulants / Mechanisms of Action
•Medications - Misuse and Abuse of Stimulants
•Medications - Atomoxetine / Alpha Agonists
Weeks 11-12: Treatment 2
•Behavior Management: Home and School
•Exercise, Nutrition, Sleep Hygiene
•Cognitive Behavioral Therapy
•Neurocognitive Training
no subject
Date: 2013-01-01 01:25 pm (UTC)no subject
Date: 2013-01-03 10:10 pm (UTC)А тут как раз и ответ сразу. :)
no subject
Date: 2013-01-01 03:14 pm (UTC)а вообще, конечно, драгстор тот ещё... и это хочу, и это хочу, и то хочу, "тё катю", как говорил один ребенок.